Infection Control Supplies Global Market Report 2024

The infection control supplies market has grown steadily in recent years. It will grow from $44.7 billion in 2023 to $46.64 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The expansion observed in the historical period can be attributed to factors such as concerns for healthcare worker safety, public health awareness campaigns, an increase in the use of antimicrobial products, adherence to healthcare facility hygiene standards, and advancements in disinfection techniques.

The infection control supplies market is expected to see steady growth in the next few years. It will grow to $55.63 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The anticipated growth in the forecast period can be attributed to the integration of digital health solutions, a focus on environmental sustainability, a shift in consumer behavior, continued demand for personal protective equipment (PPE), and evolving regulations and standards. Key trends expected in the forecast period involve remote monitoring and contact tracing, supply chain resilience and redundancy, infection prevention education and training, antimicrobial surface solutions, and a surge in demand for disinfectants and sanitizers.

The growth of the infection control supplies market is anticipated to be driven by the increasing prevalence of nosocomial infections. Nosocomial infections, acquired during healthcare delivery, necessitate the use of infection control supplies in healthcare settings to prevent their spread. According to the Centers for Disease Control and Prevention's 2021 National and State Progress Report on Healthcare-Associated Infections in November 2022, there was a 7% increase in central line-associated bloodstream infections (CLABSI) and a 5% increase in catheter-associated urinary tract infections (CAUTI) between 2020 and 2021. Thus, the rising prevalence of nosocomial infections is expected to propel the infection control supplies market.

The infection control supplies market is poised for growth due to the increasing healthcare expenditure. Healthcare expenditure, representing the total resources invested in healthcare goods and services within a specified timeframe and geographical area, is on the rise. Elevated healthcare expenditure empowers healthcare facilities to invest in infection control measures, ensuring safety and hygiene for both patients and healthcare professionals. The Centers for Medicare & Medicaid Services reported in March 2022 that national health spending is projected to increase by an average of 5.1% annually between 2021 and 2030, reaching nearly $6.8 trillion. The expected annual growth rates for Medicare and Medicaid spending during this period are 7.2% and 5.6%, respectively. Consequently, the increasing healthcare expenditure is a significant driver of the infection control supplies market.

A notable trend in the infection control supplies market is the technological advancements in sterilization equipment. Major companies in the market are developing innovative products equipped with advanced technologies to maintain their market standing. For instance, W&H Group, an Austria-based medical technology products company, introduced the Lexa Plus sterilizer, leveraging Eco Dry plus technology to provide comprehensive infection control and protection for dentists and their patients.

Innovation in product development is another key aspect of the infection control supplies market. Major companies are introducing novel products such as transparent masks to expand their customer base, boost sales, and increase revenue. Transparent masks, featuring materials that allow the wearer's mouth and facial expressions to be visible, serve specific demographics, including children, the elderly, and individuals with communication challenges. Stryker Corporation, a UK-based manufacturer of worker safety solutions, launched transparent FFP3-grade face masks in October 2021. These masks address the needs of patients with communication difficulties, ensuring effective communication in healthcare settings. The transparent masks are designed with a clear anti-fog front panel to prevent reflections and enhance lip-reading capabilities.

In June 2021, Steris, a UK-based medical equipment company, acquired Cantel Medical for an undisclosed amount. This strategic acquisition is poised to complement and expand Steris's global product and service offerings. Cantel Medical Corporation, a US-based infection control company, specializes in providing disinfectants, detergents, brushes, and related products.

Major companies operating in the infection control supplies market report are Steris Corporation, Getinge AB, 3M Company, Ecolab Inc., Johnson & Johnson Private Limited, Cardinal Health Inc., Medline Industries LP, Matachana Group, Kimberly-Clark Corporation, Halyard Health, Emergency Medical Products Inc., Certol International LLC, Schülke & Mayr GmbH, CareNow Medical Private Limited, Henry Schein Inc., Belimed AG, Sterigenics International LLC, MMM Group, Cantel Medical Corporation, Fortive Corporation, Sotera Health Company, Metrex Research LLC, Reckitt Benckiser Group plc, Pal International, Melag Medizintechnik GmbH & Co. KG, The Miele Group, Systec GmbH, Contec Inc., Continental Equipment Company, Diversey Holdings Inc.

North America was the largest region in the infection control supplies market in 2023. The regions covered in the infection control supplies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infection control supplies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products within the category of infection control supplies include disinfectants, medical face masks, surgical caps, surgical gowns, and medical gloves. Disinfectants are substances used on non-living objects to kill germs, eliminating microorganisms and preventing infections. These products are distributed through various channels, including wholesalers, retailers, pharmacies, e-commerce, and others. The end-users of infection control supplies encompass hospitals and clinics, medical device companies, pharmaceutical companies, research laboratories, and other relevant entities.

The infection control supplies market research report provides infection control supplies market statistics, including the infection control supplies industry global market size, regional shares, competitors with an infection control supplies market share, detailed infection control supplies market segments, market trends, and opportunities, and any further data you may need to thrive in the infection control supplies industry. This infection control supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The infection control supplies market consists of sales of respirators, infection control apparel, and surgical clippers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.